(Q38484762)

English

Safety and immunogenicity of a modified pox vector-based HIV/AIDS vaccine candidate expressing Env, Gag, Pol and Nef proteins of HIV-1 subtype B (MVA-B) in healthy HIV-1-uninfected volunteers: A phase I clinical trial (RISVAC02).

scientific article published on 09 September 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21907749%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Safety and immunogenicity of a modified pox vector-based HIV/AIDS vaccine candidate expressing Env, Gag, Pol and Nef proteins of HIV-1 subtype B (MVA-B) in healthy HIV-1-uninfected volunteers: A phase I clinical trial (RISVAC02) (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21907749%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

phase I clinical trial

0 references

vector-based vaccine

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21907749%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Juan García-Arriaza

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21907749%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Vicens Diaz-Brito

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21907749%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21907749%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Mª Ángeles Muñoz-Fernández

20

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21907749%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Peter Liljeström

21

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21907749%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Giuseppe Pantaleo

23

object named as

Giuseppe Pantaleo

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21907749%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

José Luis Jiménez

15

object named as

José Luis Jiménez

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21907749%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Mariano Esteban

26

object named as

Mariano Esteban

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21907749%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Beatriz Perdiguero

4

object named as

Beatriz Perdiguero

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21907749%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Carmen E Gómez

3

object named as

Carmen E Gómez

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21907749%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Juan Carlos López Bernaldo de Quirós

2

object named as

Juan Carlos López Bernaldo de Quirós

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21907749%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

16

object named as

Judit Pich

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21907749%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Joan Albert Arnaiz

17

object named as

Joan Albert Arnaiz

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21907749%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Josep Maria Gatell

24

object named as

José M Gatell

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21907749%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

19

object named as

Agathe León

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21907749%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

author name string

Jose L Nájera

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21907749%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Victoria Jiménez

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21907749%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Alberto C Guardo

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21907749%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Iñaki Pérez

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21907749%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Matilde Sánchez Conde

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21907749%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Nuria González

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21907749%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Amparo Alvarez

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21907749%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

María J Maleno

18

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21907749%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Jonathan Weber

22

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21907749%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Montserrat Plana

25

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21907749%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

language of work or name

0 references

publication date

9 September 2011

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21907749%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21907749%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

29

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21907749%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

46

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21907749%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

8309-8316

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21907749%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Preexposure chemoprophylaxis for HIV prevention in men who have sex with men

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.098

7 January 2021

Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.098

7 January 2021

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.098

7 January 2021

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.098

7 January 2021

HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.098

7 January 2021

Poxvirus vector-based HIV vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.098

7 January 2021

MVA vaccination against smallpox: clinical tests with an attenuated live vaccinia virus strain (MVA) (author's transl)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.098

7 January 2021

The complete genomic sequence of the modified vaccinia Ankara strain: comparison with other orthopoxviruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.098

7 January 2021

Smallpox vaccination and its consequences: first experiences with the highly attenuated smallpox vaccine "MVA".

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.098

7 January 2021

A human immunodeficiency virus 1 (HIV-1) clade A vaccine in clinical trials: stimulation of HIV-specific T-cell responses by DNA and recombinant modified vaccinia virus Ankara (MVA) vaccines in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.098

7 January 2021

Phase I clinical trial safety of DNA- and modified virus Ankara-vectored human immunodeficiency virus type 1 (HIV-1) vaccines administered alone and in a prime-boost regime to healthy HIV-1-uninfected volunteers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.098

7 January 2021

Induction of multifunctional human immunodeficiency virus type 1 (HIV-1)-specific T cells capable of proliferation in healthy subjects by using a prime-boost regimen of DNA- and modified vaccinia virus Ankara-vectored vaccines expressing HIV-1 Gag c

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.098

7 January 2021

A phase I trial of preventive HIV vaccination with heterologous poxviral-vectors containing matching HIV-1 inserts in healthy HIV-uninfected subjects

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.098

7 January 2021

A Phase 1 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 subtype C-modified vaccinia Ankara virus vaccine candidate in Indian volunteers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.098

7 January 2021

Phase 1 safety and immunogenicity evaluation of ADMVA, a multigenic, modified vaccinia Ankara-HIV-1 B'/C candidate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.098

7 January 2021

Phase I safety and immunogenicity evaluation of MVA-CMDR, a multigenic, recombinant modified vaccinia Ankara-HIV-1 vaccine candidate

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.098

7 January 2021

Phase 2 study of an HIV-1 canarypox vaccine (vCP1452) alone and in combination with rgp120: negative results fail to trigger a phase 3 correlates trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.098

7 January 2021

EV02: a Phase I trial to compare the safety and immunogenicity of HIV DNA-C prime-NYVAC-C boost to NYVAC-C alone

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.098

7 January 2021

EV01: a phase I trial in healthy HIV negative volunteers to evaluate a clade C HIV vaccine, NYVAC-C undertaken by the EuroVacc Consortium.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.098

7 January 2021

Broad immunogenicity of a multigene, multiclade HIV-1 DNA vaccine boosted with heterologous HIV-1 recombinant modified vaccinia virus Ankara

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.098

7 January 2021

An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.098

7 January 2021

Selective induction of host genes by MVA-B, a candidate vaccine against HIV/AIDS

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.098

7 January 2021

Head-to-head comparison on the immunogenicity of two HIV/AIDS vaccine candidates based on the attenuated poxvirus strains MVA and NYVAC co-expressing in a single locus the HIV-1BX08 gp120 and HIV-1(IIIB) Gag-Pol-Nef proteins of clade B.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.098

7 January 2021

Immunogenic profiling in mice of a HIV/AIDS vaccine candidate (MVA-B) expressing four HIV-1 antigens and potentiation by specific gene deletions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.098

7 January 2021

Differential CD4+ versus CD8+ T-cell responses elicited by different poxvirus-based human immunodeficiency virus type 1 vaccine candidates provide comparable efficacies in primates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.098

7 January 2021

The Spanish HIV BioBank: a model of cooperative HIV research

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.098

7 January 2021

A sensitive phenotypic assay for the determination of human immunodeficiency virus type 1 tropism.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.098

7 January 2021

Safety, immunogenicity and efficacy of modified vaccinia Ankara (MVA) against Dryvax challenge in vaccinia-naïve and vaccinia-immune individuals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.098

7 January 2021

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38484762&oldid=1857657804"